BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33263787)

  • 1. Demand for integrative medicine among women with breast and gynecological cancer: a multicenter cross-sectional study in Southern and Northern Germany.
    Grimm D; Mathes S; Woelber L; Van Aken C; Schmalfeldt B; Mueller V; Kiechle M; Brambs C; Paepke D
    Arch Gynecol Obstet; 2021 May; 303(5):1315-1330. PubMed ID: 33263787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of an Expert Guided Integrative Therapy Concept in Patients With Breast or Gynecological Cancer During Systemic Therapy.
    Schmidt G; Mathes S; Klein E; Kiechle M; Paepke D
    J Evid Based Integr Med; 2020; 25():2515690X20949444. PubMed ID: 32808558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse relationship between reduced fatigue and severity of anemia in oncology patients treated with integrative medicine: understanding the paradox.
    Ben-Arye E; Dahan O; Shalom-Sharabi I; Samuels N
    Support Care Cancer; 2018 Dec; 26(12):4039-4048. PubMed ID: 29882024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network.
    Fremd C; Hack CC; Schneeweiss A; Rauch G; Wallwiener D; Brucker SY; Taran FA; Hartkopf A; Overkamp F; Tesch H; Fehm T; Hadji P; Janni W; Lüftner D; Lux MP; Müller V; Ettl J; Belleville E; Sohn C; Schuetz F; Beckmann MM; Fasching PA; Wallwiener M
    Arch Gynecol Obstet; 2017 May; 295(5):1239-1245. PubMed ID: 28331996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gynecologists' attitudes toward and use of complementary and integrative medicine approaches: results of a national survey in Germany.
    Grimm D; Voiss P; Paepke D; Dietmaier J; Cramer H; Kümmel S; Beckmann MW; Woelber L; Schmalfeldt B; Freitag U; Kalder M; Wallwiener M; Theuser AK; Hack CC
    Arch Gynecol Obstet; 2021 Apr; 303(4):967-980. PubMed ID: 33201377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-reported Improvement in Side Effects and Quality of Life With Integrative Medicine in Breast Cancer Patients.
    Hack CC; Hackl J; Hüttner NBM; Langemann H; Schwitulla J; Dietzel-Drentwett S; Fasching PA; Beckmann MW; Theuser AK
    Integr Cancer Ther; 2018 Sep; 17(3):941-951. PubMed ID: 29845888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interest in Integrative Medicine Among Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study.
    Hack CC; Fasching PA; Fehm T; de Waal J; Rezai M; Baier B; Baake G; Kolberg HC; Guggenberger M; Warm M; Harbeck N; Wuerstlein R; Deuker JU; Dall P; Richter B; Wachsmann G; Brucker C; Siebers JW; Fersis N; Kuhn T; Wolf C; Vollert HW; Breitbach GP; Janni W; Landthaler R; Kohls A; Rezek D; Noesslet T; Fischer G; Henschen S; Praetz T; Heyl V; Kühn T; Krauss T; Thomssen C; Hohn A; Tesch H; Mundhenke C; Hein A; Rauh C; Bayer CM; Jacob A; Schmidt K; Belleville E; Hadji P; Brucker SY; Wallwiener D; Kümmel S; Beckmann MW; Paepke D
    Integr Cancer Ther; 2017 Jun; 16(2):165-175. PubMed ID: 27627986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demand for integrative medicine among women in pregnancy and childbed: a German survey on patients' needs.
    Schürger N; Klein E; Hapfelmeier A; Kiechle M; Paepke D
    BMC Complement Altern Med; 2018 Jun; 18(1):187. PubMed ID: 29907100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attitudes of patients with gynecological and breast cancer toward integration of complementary medicine in cancer care.
    Ben-Arye E; Schiff E; Steiner M; Keshet Y; Lavie O
    Int J Gynecol Cancer; 2012 Jan; 22(1):146-53. PubMed ID: 21912265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of complementary and alternative medicine (CAM) by women with breast cancer or gynecological cancer.
    Stöcker A; Mehnert-Theuerkauf A; Hinz A; Ernst J
    PLoS One; 2023; 18(5):e0285718. PubMed ID: 37172048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active Participation, Mind-Body Stabilization, and Coping Strategies with Integrative Medicine in Breast Cancer Patients.
    Theuser AK; Antoniadis S; Langemann H; Wasner S; Grasruck K; Dietzel-Drentwett S; Fasching PA; Beckmann MW; Hack CC
    Integr Cancer Ther; 2021; 20():1534735421990108. PubMed ID: 33645304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the Demand for Integrative Medicine Practices in Breast and Gynecological Cancer Patients.
    Schuerger N; Klein E; Hapfelmeier A; Kiechle M; Brambs C; Paepke D
    Breast Care (Basel); 2019 Mar; 14(1):35-40. PubMed ID: 31019441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer patients' satisfaction with individual therapy goals and treatment in a standardized integrative medicine consultancy service.
    Hack CC; Antoniadis S; Hackl J; Langemann H; Schwitulla J; Fasching PA; Beckmann MW; Theuser AK
    Arch Gynecol Obstet; 2018 Jul; 298(1):147-156. PubMed ID: 29704060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of biologically-based complementary medicine in breast and gynecological cancer patients during systemic therapy.
    Drozdoff L; Klein E; Kiechle M; Paepke D
    BMC Complement Altern Med; 2018 Sep; 18(1):259. PubMed ID: 30249217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Providing integrative care in the pre-chemotherapy setting: a pragmatic controlled patient-centered trial with implications for supportive cancer care.
    Ben-Arye E; Dahly H; Keshet Y; Dagash J; Samuels N
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1825-1833. PubMed ID: 29980837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a patient-tailored integrative medicine program on gastro-intestinal concerns and quality of life in patients with breast and gynecologic cancer.
    Shalom-Sharabi I; Samuels N; Lavie O; Lev E; Keinan-Boker L; Schiff E; Ben-Arye E
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1243-1254. PubMed ID: 28247032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative Medicine for Female Patients with Gynecologic Cancer.
    Ben-Arye E; Samuels N; Lavie O
    J Altern Complement Med; 2018; 24(9-10):881-889. PubMed ID: 30247969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of integrative medicine centers in the USA and Germany: a mixed method study.
    Lim E; Vardy JL; Oh B; Dhillon HM
    Support Care Cancer; 2017 Jun; 25(6):1865-1872. PubMed ID: 28124123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a complementary/integrative medicine program on the need for supportive cancer care-related medications.
    Shalom-Sharabi I; Samuels N; Lev E; Lavie O; Keinan-Boker L; Schiff E; Ben-Arye E
    Support Care Cancer; 2017 Oct; 25(10):3181-3190. PubMed ID: 28434097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Oncological Second Opinions in a Certified University Breast and Gynecological Cancer Center in Relation to Complementary and Alternative Medicine.
    Hack CC; Wasner S; Meyer J; Häberle L; Jud S; Hein A; Wunderle M; Emons J; Gass P; Fasching PA; Egloffstein S; Beckmann MW; Lux MP; Loehberg CR
    Complement Med Res; 2020; 27(6):431-439. PubMed ID: 32544918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.